/ Natco Pharma Informs About Press Release ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Monday, 2 July 2018

Natco Pharma has informed about press release titled, 'NATCO launches fixed dose combination of Sofosbuvir-Daclatasvir drug for Hepatitis C treatment in INDIA'.

The above information is a part of company’s filings submitted to BSE.

For Quick Trial – 8962000225 ✔

or mail us here: info@ways2capital.com
✆ - 0731 6626191  | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717